BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 19376755)

  • 1. [Neonatal screening of sickle cell disease in the Balearic Islands Autonomous Community. Pilot study in anonymous unrelated population].
    López-Escribano H; Vila Vidal M; Barceló Bennassar A; Riesco Prieto M; Ayllón Gatnau O
    An Pediatr (Barc); 2009 May; 70(5):429-33. PubMed ID: 19376755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates.
    Al Hosani H; Salah M; Osman HM; Farag HM; Anvery SM
    East Mediterr Health J; 2005 May; 11(3):300-7. PubMed ID: 16602448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal screening for sickle cell disease in France.
    Bardakdjian-Michau J; Bahuau M; Hurtrel D; Godart C; Riou J; Mathis M; Goossens M; Badens C; Ducrocq R; Elion J; Perini JM
    J Clin Pathol; 2009 Jan; 62(1):31-3. PubMed ID: 19103855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies.
    Tshilolo L; Kafando E; Sawadogo M; Cotton F; Vertongen F; Ferster A; Gulbis B
    Public Health; 2008 Sep; 122(9):933-41. PubMed ID: 18555498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal screening for sickle cell disorders in Ouagadougou, Burkina Faso: a pilot study.
    Kafando E; Sawadogo M; Cotton F; Vertongen F; Gulbis B
    J Med Screen; 2005; 12(3):112-4. PubMed ID: 16156939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns.
    Tshilolo L; Aissi LM; Lukusa D; Kinsiama C; Wembonyama S; Gulbis B; Vertongen F
    J Clin Pathol; 2009 Jan; 62(1):35-8. PubMed ID: 19103857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early detection of sickle cell anemia and other hemoglobinopathies in neonates in the Autonomous Community of Madrid. A pilot study].
    Dulín Iñígueza E; Cantalejo López MA; Cela de Julián ME; Galarón García P
    An Pediatr (Barc); 2003 Feb; 58(2):146-55. PubMed ID: 12628145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005.
    Streetly A; Clarke M; Downing M; Farrar L; Foo Y; Hall K; Kemp H; Newbold J; Walsh P; Yates J; Henthorn J
    J Med Screen; 2008; 15(1):9-13. PubMed ID: 18416948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neonatal detection of sickle cell disease].
    Bardakdjian-Michau J
    J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1 Suppl):1S61-4. PubMed ID: 12592166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening for sickle cell disease in a Nigerian hospital.
    Odunvbun ME; Okolo AA; Rahimy CM
    Public Health; 2008 Oct; 122(10):1111-6. PubMed ID: 18486954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening.
    Peters M; Fijnvandraat K; van den Tweel XW; Garre FG; Giordano PC; van Wouwe JP; Pereira RR; Verkerk PH
    Arch Dis Child; 2010 Oct; 95(10):822-5. PubMed ID: 20576657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
    Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for sickle cell disease on dried blood: a new approach evaluated on 27,000 Belgian newborns.
    Boemer F; Vanbellinghen JF; Bours V; Schoos R
    J Med Screen; 2006; 13(3):132-6. PubMed ID: 17007654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatographic analysis of Hb S for the diagnosis of various sickle cell disorders in Pakistan.
    Hashmi NK; Moiz B; Nusrat M; Hashmi MR
    Ann Hematol; 2008 Aug; 87(8):639-45. PubMed ID: 18465131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing neonatal screening for haemoglobinopathies in the Netherlands.
    Bouva MJ; Mohrmann K; Brinkman HB; Kemper-Proper EA; Elvers B; Loeber JG; Verheul FE; Giordano PC
    J Med Screen; 2010; 17(2):58-65. PubMed ID: 20660432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Starting neonatal screening for haemoglobinopathies in The Netherlands.
    Giordano PC
    J Clin Pathol; 2009 Jan; 62(1):18-21. PubMed ID: 19103852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal haemoglobinopathy screening: review of a 10-year programme in Brussels.
    Gulbis B; Ferster A; Cotton F; Lebouchard MP; Cochaux P; Vertongen F
    J Med Screen; 2006; 13(2):76-8. PubMed ID: 16792829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neonatal screening for sickle cell disease at the Nice University Hospital: the last 8 years].
    Berthet S; Monpoux F; Soummer AM; Bérard E; Sarles J; Badens C
    Arch Pediatr; 2010 Dec; 17(12):1652-6. PubMed ID: 21087846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neonatal screening for sickle cell disease in the Consorci Sanitari de Mataro. Rationale and first results].
    Cabot Dalmau A; Casado Toda M; Barberán Pérez J; Roqueta Sureda M; Martorell Aymerich Q; Bosch Llobet A; Rovira Fernández JM
    An Esp Pediatr; 1998 Aug; 49(2):157-60. PubMed ID: 9773551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MALDI-TOF MS profiling as the first-tier screen for sickle cell disease in neonates: matching throughput to objectives.
    Hachani J; Duban-Deweer S; Pottiez G; Renom G; Flahaut C; Périni JM
    Proteomics Clin Appl; 2011 Aug; 5(7-8):405-14. PubMed ID: 21751410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.